SEARCH RESULTS FOR:

David Craford

PRESIDENT AND CEO, CYTOBANK
Cytobank is developing and commercializing the leading SaaS platform for machine learning-based analysis of high-complexity life sciences data.

Arturo Bettati

MANAGING DIRECTOR LATIN AMERICA, HALDOR TOPSOE
Latin America Petrochemicals and Chemicals 2018 APLA Special Edition
The Danish company is a world leader in catalysis and process technology.

ARA - France's Other Aerospace Valley

Auvergne-Rhône-Alpes Aerospace 2018
The region boasts a strong offering to the aerospace industry, as it is home to a large number of thriving Tier 1 and Tier 2 suppliers for OEMs, as well as many SMEs offering more niche products.

Olivier Rousset

MARKET MANAGER SPECIAL PARTS, PROFORM
Auvergne-Rhône-Alpes Aerospace 2018
Proform specializes in tube bending, forming, assembling, hydroforming manufacturing and design, for aerospace and defense.

Bernard Lavergne

BERNARD LAVERGNE, PRESIDENT, SN AUVERGNE AERONAUTIQUE
Auvergne-Rhône-Alpes Aerospace 2018
SN Auvergne Aeronautique is expanding its scope, using the synergies created with the Figeac Aero Group.

Franck Picard

OPERATIONAL DIRECTOR, ACNIS INTERNATIONAL
Auvergne-Rhône-Alpes Aerospace 2018
A conversation around the titanium alloy distribution in Europe’s aerospace industry.

Jean-Michel Deck

BUSINESS DEVELOPMENT, COMPOSE
Auvergne-Rhône-Alpes Aerospace 2018
Compose designs and manufactures tools to process thermoplastics and composite materials.

Şahin Özdemir

CHAIRMAN OF THE BOARD, MITTO CONSULTANCY
Turkey Mining 2018
Özdemir discusses government incentives to mining in Turkey, as well as the social issues surrounding project development.

Paul Tanico

CEO, NEURODIAGNOSTICS LLC
NeuroDiagnostics is focused on its DISCERN™ test for the diagnosis of Alzheimer’s disease.

Robert McLeod

PRESIDENT AND CEO, IDM MINING
A summary of the latest developments at the Red Mountain gold project, located in B.C.’s ‘Golden Triangle’.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS